Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Income towards Parent Company: 2009-2019

Historic Income towards Parent Company for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to $37.0 million.

  • Neurocrine Biosciences' Income towards Parent Company rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $39.3 million, marking a year-over-year decrease of 57.93%. This contributed to the annual value of $37.0 million for FY2019, which is 75.32% up from last year.
  • Neurocrine Biosciences' Income towards Parent Company amounted to $37.0 million in FY2019, which was up 75.32% from $21.1 million recorded in FY2018.
  • Neurocrine Biosciences' 5-year Income towards Parent Company high stood at $37.0 million for FY2019, and its period low was -$142.5 million during FY2017.
  • Its 3-year average for Income towards Parent Company is -$28.1 million, with a median of $21.1 million in 2018.
  • In the last 5 years, Neurocrine Biosciences' Income towards Parent Company tumbled by 52.90% in 2016 and then soared by 114.81% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Income towards Parent Company (Yearly) stood at -$92.3 million in 2015, then tumbled by 52.90% to -$141.1 million in 2016, then decreased by 1.03% to -$142.5 million in 2017, then surged by 114.81% to $21.1 million in 2018, then skyrocketed by 75.32% to $37.0 million in 2019.